How the TMB and Plaintiffs’ Attorneys May Scrutinize AI Use in Med Spa Patient Care
AI is becoming increasingly common in med spas, offering tools that assist with patient intake, treatment recommendations, clinical documentation, marketing, and administrative operations. Although these technologies may improve efficiency, their use in patient care creates legal and regulatory concerns that med spa owners and medical directors should carefully consider.

AI Does Not Replace Judgment
One of the most significant concerns surrounding AI in med spas is the potential for practitioners to rely too heavily on automated recommendations. AI tools may assist with evaluating patient information, identifying contraindications, suggesting treatments, or generating clinical recommendations. However, these tools may produce inaccurate, incomplete, or misleading results.
A provider who accepts an AI-generated recommendation without independently evaluating the patient may face scrutiny if the recommendation contributes to an adverse outcome. For example, an AI system might overlook a relevant medical history, fail to identify a contraindication, or recommend a treatment that is inappropriate for a particular patient.
The TMB may examine whether the spa independently assessed the patient's condition, considered relevant clinical information, and exercised appropriate judgment. Plaintiffs’ attorneys may similarly argue that the medical director delegated critical decision-making to a technology that lacked the ability to exercise professional judgment.
AI should therefore function as a supplemental resource rather than a substitute for clinical evaluation, professional judgment, or appropriate medical supervision.
AI-Generated Documentation and Medical Record Accuracy
AI-assisted documentation presents another potential source of regulatory and litigation risk. Some systems generate medical notes or summarize patient encounters. Although these tools can reduce administrative burdens, they may introduce errors that affect the integrity of the patient’s record.
During a TMB investigation, documentation may be evaluated to determine whether the spa adequately assessed the patient and provided appropriate care. Plaintiffs’ attorneys may compare AI-generated notes with other evidence, including patient communications, treatment records, consent forms, and testimony.
Med spa providers should carefully review AI-generated documentation before approving or incorporating it into the patient’s record. The record should accurately reflect the services performed, the patient's condition, the provider’s clinical reasoning, and the treatment provided.
AI should never be permitted to generate unsupported examination findings or create the appearance that a service was performed when it was not.
Informed Consent and Disclosure of AI Use
AI may also raise informed-consent concerns when it materially influences patient evaluation or treatment. Patients may reasonably have questions about whether AI is being used to analyze their information, recommend treatment, or assist in decisions affecting their care.
The legal significance of disclosure will depend on the nature of the technology, its role in treatment, and applicable law. Not every administrative use of AI necessarily requires separate patient consent. However, med spas should carefully consider whether patients should be informed when AI plays a meaningful role in clinical decision-making or when its use creates material risks or limitations.
Plaintiffs’ attorneys may argue that a patient was not adequately informed about the process used to develop a treatment recommendation. They may also examine whether the spa explained the limitations of AI-assisted assessments or whether the patient was led to believe that an automated recommendation represented an independent clinical evaluation.
Med spas should evaluate their consent procedures and patient disclosures based on the specific AI tools being used rather than relying on a generic consent form that does not address the technology's actual role.
Privacy, Confidentiality, and AI Vendors
AI systems may process sensitive patient information, including medical histories, photographs, treatment records, and identifying information. Uploading this information into an AI platform without appropriate safeguards may create privacy and confidentiality concerns.
The TMB, plaintiffs’ attorneys, and other regulators may examine how patient information was collected, transmitted, stored, and used. Depending on the circumstances, unauthorized disclosure or improper handling of protected health information may also raise HIPAA concerns.
Med spas should evaluate AI vendors before integrating their products into patient care. Relevant considerations include data security, confidentiality protections, access controls, retention policies, and whether patient information may be used to train or improve the vendor’s AI models.
Establishing an AI Compliance Framework
Med spas should develop written policies governing AI use before implementing these technologies in patient care. Policies should identify approved tools, describe permitted uses, establish review requirements, and address patient privacy and confidentiality.
Medical directors should understand how AI is being used by personnel and should evaluate whether the technology is appropriate for the services offered. Staff should receive training regarding AI limitations, inaccurate outputs, patient confidentiality, and circumstances requiring physician review.
Periodic audits can help identify inappropriate reliance on AI, inaccurate documentation, and inconsistencies between AI recommendations and actual clinical decisions. Med spas should also maintain appropriate records of AI-related policies, training, and oversight activities.
When an adverse outcome occurs, the med spa should preserve relevant records and avoid deleting or altering AI-generated material that may be connected to the patient's care or a potential claim.
Conclusion on How the TMB and Plaintiffs’ Attorneys May Scrutinize AI Use in Med Spa Patient Care
AI offers med spas opportunities to improve efficiency and support patient care, but its use introduces additional regulatory and litigation considerations. The Texas Medical Board may examine whether medical directors maintained appropriate clinical judgment and oversight, while plaintiffs’ attorneys may investigate whether AI contributed to an injury, inaccurate documentation, or inadequate informed consent.
The safest approach is to treat AI as a tool that supports, rather than replaces, professional judgment. By establishing clear policies, reviewing AI-generated information, protecting patient data, and maintaining accurate records, Texas med spas can better manage the legal risks associated with incorporating AI into patient care.
Feel free to reach out if you need more specific information or further clarification.
Weitz Morgan is a leading law firm in Texas in providing comprehensive advice and guidance to med spas. With a deep understanding of the unique challenges and complexities faced by this rapidly growing industry, our team of experienced attorneys is dedicated to helping med spas navigate the legal landscape successfully.
We recognize that med spas operate at the intersection of healthcare and beauty, which necessitates a multifaceted approach to representation. Our firm offers a range of services, including a flat-fee med spa formation package and an outside general counsel subscription, tailored to meet the specific needs of med spas, ensuring compliance, mitigating risks, protecting licenses, and fostering a legally sound business environment.


Comments